Education
About Us
Working with TipRanks
Follow Us
NovaBridge Biosciences (NBP)
NASDAQ:NBP
Total Valuation
NovaBridge Biosciences has a market cap or net worth of $518.81M. The enterprise value is $156.81M.
Market Cap$518.81M
Enterprise Value$156.81M
Share Statistics
NovaBridge Biosciences has 115,119,490 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding115,119,490
Owned by Insiders―
Owned by Institutions14.61%
Financial Efficiency
NovaBridge Biosciences’s return on equity (ROE) is -0.81 and return on invested capital (ROIC) is -183.06%.
Return on Equity (ROE)-0.81
Return on Assets (ROA)-0.76
Return on Invested Capital (ROIC)-183.06%
Return on Capital Employed (ROCE)-1.84
Revenue Per Employee0.00
Profits Per Employee-1.55M
Employee Count32
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NovaBridge Biosciences is ―. NovaBridge Biosciences’s PEG ratio is 0.00570.
PE Ratio―
PS Ratio0.00
PB Ratio0.34
Price to Fair Value0.34
Price to FCF-1.31
Price to Operating Cash Flow246.04
PEG Ratio0.00570
Income Statement
In the last 12 months, NovaBridge Biosciences had revenue of 0.00 and earned -162.26M in profits. Earnings per share was -4.46.
Revenue0.00
Gross Profit0.00
Operating Income-375.36M
Pretax Income-362.73M
Net Income-162.26M
EBITDA-373.45M
Earnings Per Share (EPS)-4.46
Cash Flow
In the last 12 months, operating cash flow was 1.85M and capital expenditures 0.00, giving a free cash flow of 1.85M billion.
Operating Cash Flow1.85M
Free Cash Flow1.85M
Free Cash Flow per Share0.02
Dividends & Yields
NovaBridge Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.19
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)473.49K
Important Dates
NovaBridge Biosciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
NovaBridge Biosciences as a current ratio of 20.90, with Debt / Equity ratio of 1.26%
Current Ratio20.90
Quick Ratio20.90
Debt to Market Cap0.00
Net Debt to EBITDA0.17
Interest Coverage Ratio0.00
Taxes
In the past 12 months, NovaBridge Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NovaBridge Biosciences EV to EBITDA ratio is -0.01, with an EV/FCF ratio of -0.09.
EV to Sales0.00
EV to EBITDA-0.01
EV to Free Cash Flow-0.09
EV to Operating Cash Flow-0.09
Balance Sheet
NovaBridge Biosciences has $228.27M in cash and marketable securities with $3.27M in debt, giving a net cash position of $225.00M billion.
Cash & Marketable Securities$228.27M
Total Debt$3.27M
Net Cash$225.00M
Net Cash Per Share$1.95
Tangible Book Value Per Share$2.48
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NovaBridge Biosciences is $8.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$8.33
Price Target Upside85.11% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast-100.00%
EPS Growth Forecast72.45%